Anchor Therapeutics Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 4

Employees

  • Latest Deal Type
  • M&A

Anchor Therapeutics General Information

Description

Developer of a pharmaceutical platform designed to treat cancer, inflammation, metabolism, heart disease, and pain. The company's pharmaceutical platform includes the development of Pepducin lipopeptide drug candidates and molecules that target the intracellular domains of G protein-coupled receptors (GPCRs) to allosterically modulate GPCR signaling, providing healthcare professionals with new treatment options for regenerative medicine, diabetes, inflammation, and cancer.

Contact Information

Formerly Known As
Ascent Therapeutics, Ascent Therapeutics Inc
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • One Kendall Square
  • Building 200, Suite 2203
  • Cambridge, MA 02139
  • United States
+1 (508)
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • One Kendall Square
  • Building 200, Suite 2203
  • Cambridge, MA 02139
  • United States
+1 (508)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anchor Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 19-Aug-2016 Completed Profitable
5. Merger/Acquisition 20-Mar-2015 Completed Profitable
4. Early Stage VC 01-May-2012 Completed Profitable
3. Early Stage VC 23-Aug-2010 Completed Profitable
2. Early Stage VC (Series B) 20-Aug-2010 $10M $29M Completed Profitable
1. Early Stage VC (Series A) 18-Nov-2008 $19M $19M Completed Profitable
To view Anchor Therapeutics’s complete valuation and funding history, request access »

Anchor Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Anchor Therapeutics’s complete cap table history, request access »

Anchor Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a pharmaceutical platform designed to treat cancer, inflammation, metabolism, heart disease, and pain. The
Drug Discovery
Cambridge, MA
4 As of 2021

Lexington, MA
 

Burnaby, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Anchor Therapeutics Competitors (55)

One of Anchor Therapeutics’s 55 competitors is Voyager Therapeutics, a Formerly VC-backed company based in Lexington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Voyager Therapeutics Formerly VC-backed Lexington, MA
Qu Biologics Private Equity-Backed Burnaby, Canada
Vera Therapeutics Formerly VC-backed Brisbane, CA
Vertex Pharmaceuticals Formerly VC-backed Boston, MA
Sanofi Pasteur Corporation Paris, France
You’re viewing 5 of 55 competitors. Get the full list »

Anchor Therapeutics Patents

Anchor Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3021861-A1 Apj receptor compounds Inactive 18-Jul-2013
US-20160159861-A1 Apj receptor compounds Inactive 18-Jul-2013
WO-2015010045-A1 Apj receptor compounds Inactive 18-Jul-2013
AU-2013208109-A1 Apj receptor compounds Inactive 09-Jan-2012
CA-2860740-A1 Apj receptor compounds Inactive 09-Jan-2012 C07K7/08
To view Anchor Therapeutics’s complete patent history, request access »

Anchor Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anchor Therapeutics Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Acer Therapeutics Corporation Majority
HealthCare Ventures Venture Capital Minority
Novartis Venture Fund Corporate Venture Capital Minority
TVM Capital Venture Capital Minority
To view Anchor Therapeutics’s complete investors history, request access »

Anchor Therapeutics FAQs

  • When was Anchor Therapeutics founded?

    Anchor Therapeutics was founded in 2006.

  • Where is Anchor Therapeutics headquartered?

    Anchor Therapeutics is headquartered in Cambridge, MA.

  • What is the size of Anchor Therapeutics?

    Anchor Therapeutics has 4 total employees.

  • What industry is Anchor Therapeutics in?

    Anchor Therapeutics’s primary industry is Drug Discovery.

  • Is Anchor Therapeutics a private or public company?

    Anchor Therapeutics is a Private company.

  • What is Anchor Therapeutics’s current revenue?

    The current revenue for Anchor Therapeutics is .

  • How much funding has Anchor Therapeutics raised over time?

    Anchor Therapeutics has raised $34M.

  • Who are Anchor Therapeutics’s investors?

    Acer Therapeutics, HealthCare Ventures, Novartis Venture Fund, and TVM Capital have invested in Anchor Therapeutics.

  • Who are Anchor Therapeutics’s competitors?

    Voyager Therapeutics, Qu Biologics, Vera Therapeutics, Vertex Pharmaceuticals, and Sanofi Pasteur are some of the 55 competitors of Anchor Therapeutics.

  • When was Anchor Therapeutics acquired?

    Anchor Therapeutics was acquired on 19-Aug-2016.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process